WRBC
AGN

W.R. Berkley Corp’s Allergan plc AGN Stock Holding History

W.R. Berkley Corp’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-56,915
Closed -$10.1M – 154
2020
Q1 		$10.1M Buy
56,915
+37,100
+187% +$6.99M 1.19% 23
2019
Q4 		$3.79M Hold
19,815
– – 0.69% 39
2019
Q3 		$3.33M Buy
+19,815
New +$3.23M 0.55% 49

Other funds holding AGN

AJ
Ashburton (Jersey) St Helier, Jersey $227M AUM
C
Cerebellum San Francisco, California $21.5M AUM
B
Barings Charlotte, North Carolina $6.19B AUM 16.5% 1-Year Est. Return
JJ
JDC-JSC New York $20.8M AUM 30.94% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
OPS
Orion Portfolio Solutions Omaha, Nebraska $10.2B AUM 6.73% 1-Year Est. Return

W.R. Berkley Corp's AGN Position: Q2 2020 in Review

W.R. Berkley Corp sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 56,915 shares — an estimated $10.1M sold.

W.R. Berkley Corp first reported a position in AGN in Q3 2019 and held it in 3 quarters. The position peaked at $10.1M in Q1 2020. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • W.R. Berkley Corp reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • W.R. Berkley Corp sold 56,915 Allergan plc shares in Q2 2020, an estimated $10.1M.
  • W.R. Berkley Corp first reported a position in Allergan plc in Q3 2019 and held it in 3 quarters.
  • W.R. Berkley Corp's Allergan plc position peaked at $10.1M in Q1 2020.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on W.R. Berkley Corp's 13F filing for Q2 2020, filed 14 Aug 2020.